The Latest Breaking News from Wall Street

Hormel Foods has lagged behind the broader market over the past year, and analysts are cautious about the stock's prospects.

Despite Zimmer Biomet underperforming the broader market over the past year, analysts remain moderately bullish on the stock’s prospects.

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

Visa's stock has been underperforming the broader financial sector, falling from its all-time high. Despite this, Wall Street analysts are optimistic and anticipate upsides in the stock.

Revenue at Amazon Web Services increases to $25bn as retail giant releases earnings report surpassing Wall Street expectations

The Federal Reserve and Wall Street should look below the headline March jobs report released Friday to three numbers that matter the most for inflation and interest rates -- labor force participation, unemployment rate, and hourly earnings.

High-yield dividend stocks, such as Hasbro and Vail Resorts, might be among the next consumer-facing companies to cut their shareholder payouts this year, based on a few key metrics.

Despite macroeconomic headwinds, these exceptional growth stocks showed resilience in 2023 with strengthened financials. As we head into a new year, Wall Street's optimism regarding their long-term prospects is not surprising.

As we head into 2024, Wall Street analysts are the most bullish on Amazon in the FAANG space, while the consensus expects Netflix shares to decline over the next year. Here's a closer look at what experts are forecasting for FAANG names next year.